Bizarre Patents
A helium-filled sun shade for protecting individuals engaged in outdoor activities.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6811796 | Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof A method for prevention or therapy of pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria by administration of two kinds of crude drugs—seeds of Cucurbita moschata and flowers of Carthamus tinctorius—and at least one crude dru... | 11/02/2004 |
| 6790849 | Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the treatment, m... | 09/14/2004 |
| 6787532 | Formulation containing anti-inflammatory androstane derivatives There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilising agent for assisting the solubilisation of th... | 09/07/2004 |
| 6770619 | Lung surfactant compositions with dynamic swelling behavior Lung surfactant compositions are provided which can form a swelling phase when dispersed in a medium containing electrolytes. Hereby, a more active spreading of the lung surfactant into the alveoli can be obtained after administration to the lungs. Further provided ... | 08/03/2004 |
| 6770635 | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions Adverse inflammatory reactions can be treated by administrating to an organism a composition having diglucosylamine as the active ingredient. The preferred compound is di-Beta-D-glucopyranosylamine. A simple method for making diglucosylamine in high purity is obtain... | 08/03/2004 |
| 6767901 | Ciclesonide contained pharmaceutical composition for application to mucosa The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, ciclesonide, and an aqueous medium, and having an osmotic pressure of less than 290 ... | 07/27/2004 |
| 6759049 | Pharmaceutical or dietetic mushroom-based compositions The invention concerns the field of pharmaceutics and dietetics. More particularly, the invention concerns pharmaceutical and/or dietetic mushroom-based compositions, characterised in that they contain one or several edible mushrooms with therapeutic properties and ... | 07/06/2004 |
| 6756369 | Diagnosis and management of infection caused by Chlamydia The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly C. pneumoniae. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stag... | 06/29/2004 |
| 6753021 | Biologically active chloroform fraction of an extract obtained from a mangrove plant Salvadora persica L The invention discloses a process of extracting, fractionating and purifying bioactive molecules from an associated mangrove plant, methods of screening for pharmacological activities of crude extract, its fractions and purified compounds and use of the chloroform f... | 06/22/2004 |
| 6743429 | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases The present invention relates to the use of calcitonin gene-related peptide (CGRP) in the prevention and alleviation of asthmatic symptoms. In contrast to other therapeutic agents now in use, CGRP combines both bronchoprotector and anti-inflammatory properties. Furt... | 06/01/2004 |
| 6737044 | Aerosol composition An aerosol composition comprising a propellant and a first particulate material comprising particle having a median aerodynamic diameter within the range 0.05 to 11 μm, such as a medicament suitable for pulmonary inhalation, and a second particulate material compri... | 05/18/2004 |
| 6723713 | Use of mometasone furoate for treating upper airway diseases The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis ... | 04/20/2004 |
| 6713509 | Controlled release formulation for treating COPD This invention relates to a controlled or sustained release formulation designed to deliver a PDE4 inhibitor for treating an inflammatory disease such as asthma or COPD and the like. ... | 03/30/2004 |
| 6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasure... | 03/09/2004 |
| 6699459 | Methods of treating lung inflammation The present invention relates to a method of treating lung inflammation in a subject which includes administering butylated hydroxyanisol to the subject in an amount effective to treat lung inflammation. The invention also relates to methods of inhibiting... | 03/02/2004 |
| 6689810 | Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide The present invention pertains to a method for treating a pulmonary disease state in mammals by altering indigenous in vivo levels of nitric oxide in mammalian cells. The method comprises contacting the mammalian cells with a therapeutically effective amo... | 02/10/2004 |
| 6689748 | Method of treating mast cell activation-induced diseases with a proteoglycan The invention provides a method for preventing and treating the harmful biological effects of biochemicals secreted from activated mast cells in the organism of warm blooded animals and more especially human beings, said effects being associated with alle... | 02/10/2004 |
| 6685932 | Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof The design of antagonists of 4-helix bundle cytokine specific receptors, mimetic peptides that are able to act as such antagonists and their use as pharmaceutical agents is disclosed.... | 02/03/2004 |
| 6677322 | Use of mometasone furoate for treating airway passage and lung diseases The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergi... | 01/13/2004 |
| 6677323 | Use of mometasone furoate for treating airway passage and lung diseases The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergi... | 01/13/2004 |
| 6670394 | Method for treating COPD This invention relates to a method for the prophylaxis of or for treating COPD by administering a PDE4 inhibitor which has a defined therapeutic ratio.... | 12/30/2003 |
| 6664227 | Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains Methods are provided for treating or inhibiting the formation of tissue fibrosis using IL-13 antagonists, including without limitation soluble forms of the IL-13 receptor.... | 12/16/2003 |
| 6645486 | Method of treatment with IL-9 conjugate The methods of this invention relate to immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. This invention also relates to the treatment of pathological conditions, e.... | 11/11/2003 |
| 6645492 | Methods of treating asthma with interleukin-9 receptor antibodies A C to T DNA variation at position 3365 in exon 5 of the human Asthma Associated Factor 1 (AAF1) produces the predicted amino acid substitution of a methionine for a threonine at codon 117 of AAF1. When this substitution occurs in both alleles in one indi... | 11/11/2003 |
| 6630176 | Herbal remedies for treating allergies and asthma The present invention provides herbal compositions that can prevent or reduce the severity, intensity, or duration of allergic and/or asthmatic symptoms and/or can prevent or delay the development of an allergic or asthmatic response to an antigen. The co... | 10/07/2003 |
| 6630466 | Medicament compositions containing anticholinergically-effective compounds and salmeterol The present invention relates to new medicament compositions based on anticholinergic compounds, which have a long-lasting effect, and salmeterol, processes for their production and their use in the therapy of respiratory ailments.... | 10/07/2003 |
| 6623723 | Method for treating bronchial constriction and bronchospasm The present invention is directed to a method for treating bronchial constriction in mammals. The method comprises contacting mammalian lung with a compound selected from the group consisting of pyruvate and pyruvate precursors. The compound is present in... | 09/23/2003 |
| 6617355 | Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown Asthma is ameliorated, and mild or moderate asthma is prevented from progressing to more severe asthma by administering agents which prevent and/or accommodate for S-nitrosothiol breakdown.... | 09/09/2003 |
| 6608054 | Pharmaceutical compositions based on anticholinergics and endothelin antagonists The present invention relates to novel pharmaceutical compositions based on anticholinergics and endothelin antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.... | 08/19/2003 |
| 6555105 | Method of treatment with a RANTES antagonist polypeptide Modifications to RANTES can result in the modified polypeptide acting as a RANTES or MIP-1 antagonist. Such antagonists can be used in therapy to reduce inflammation. They are also useful in studying the properties of RANTES or of MIP-1.... | 04/29/2003 |
| 6555576 | Method for treating exercise induced asthma Methods of treating exercise-induced asthma using a PDE-4 inhibitor are disclosed.... | 04/29/2003 |
| 6548500 | Reverse-turn mimetics and methods relating thereto Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetics have utility in the treatment of cell adhesion-indicated diseases, su... | 04/15/2003 |
| 6548540 | Method of treating cancer using dithiocarbamate derivatives Dithiocarbamate, particularly tetraethylthiuram disulfide, and thiocarbamate anions strongly inhibit the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and cerulopla... | 04/15/2003 |
| 6538002 | Cyclopentyl modulators of chemokine receptor activity The present in to s directed to compounds of the formula I: ##STR1## (wherein R1, R2, R3, R7, R8, X, Y, Z, x and y are defined herein) which are useful as modulators of chemokine receptor activity. In... | 03/25/2003 |
| 6537524 | Combinations of formoterol and a tiotropium salt A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or separate... | 03/25/2003 |
| 6534486 | 2-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivatives A series of 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives with broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.... | 03/18/2003 |
| 6528494 | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives There are provided according to the invention novel compounds of formula I ##STR1## wherein R1, R2 and R3 are as described in the specification, processes for preparing them, formulations containing them and their use in t... | 03/04/2003 |
| 6518274 | Use of cyclopentabenzofuran-derivatives for combating (NF-.kappa.B)-dependent diseases The invention relates to the use of cycloventabenzofuran derivatives for the production of a medicament for the treatment of nuclear factor of .kappa.B-dependent diseases.... | 02/11/2003 |
| 6506377 | Interferon-alpha mediated upregulation of aquaporin expression A method for enhancing the expression of aquaporin proteins by contacting aquaporin producing cells with interferon- is described. The method enables treatment of patients afflicted with disease states characterized by xerosis.... | 01/14/2003 |
| 6506796 | Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis Methods of cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of 6-3-(1-adamantyl)-4-hydroxyphenyl)-2-naphthan... | 01/14/2003 |
